vs
BANC OF CALIFORNIA, INC.（BANC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
BANC OF CALIFORNIA, INC.的季度营收约是REPLIGEN CORP的1.4倍（$286.9M vs $197.9M），BANC OF CALIFORNIA, INC.净利率更高（25.1% vs 6.7%，领先18.4%），REPLIGEN CORP同比增速更快（13.6% vs 7.9%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -23.7%）
加州银行是一家美国金融机构，总部位于加利福尼亚州洛杉矶，在加州设有80家分支机构，业务网点还覆盖科罗拉多州丹佛、北卡罗来纳州达勒姆等地，包括纽约、芝加哥在内的全美员工约2000人。该行提供多元化的存贷款产品与服务，专注为中小市场企业及获创投注资的企业提供银行与财资管理解决方案。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BANC vs RGEN — 直观对比
营收规模更大
BANC
是对方的1.4倍
$197.9M
营收增速更快
RGEN
高出5.8%
7.9%
净利率更高
BANC
高出18.4%
6.7%
两年增速更快
RGEN
近两年复合增速
-23.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $286.9M | $197.9M |
| 净利润 | $72.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 25.1% | 6.7% |
| 营收同比 | 7.9% | 13.6% |
| 净利润同比 | 34.3% | 143.9% |
| 每股收益（稀释后） | $0.39 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BANCRGEN
| Q1 26 | $286.9M | — | ||
| Q4 25 | $458.5M | $197.9M | ||
| Q3 25 | $466.8M | $188.8M | ||
| Q2 25 | $453.1M | $182.4M | ||
| Q1 25 | $440.3M | $169.2M | ||
| Q4 24 | $453.5M | $174.1M | ||
| Q3 24 | $431.4M | $154.9M | ||
| Q2 24 | $492.4M | $154.1M |
净利润BANCRGEN
| Q1 26 | $72.0M | — | ||
| Q4 25 | $77.4M | $13.3M | ||
| Q3 25 | $69.6M | $14.9M | ||
| Q2 25 | $28.4M | $14.9M | ||
| Q1 25 | $53.6M | $5.8M | ||
| Q4 24 | $56.9M | $-30.3M | ||
| Q3 24 | $8.8M | $-654.0K | ||
| Q2 24 | $30.3M | $3.3M |
毛利率BANCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率BANCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 21.8% | 9.0% | ||
| Q3 25 | 19.8% | 8.9% | ||
| Q2 25 | 10.6% | 7.6% | ||
| Q1 25 | 16.6% | 3.9% | ||
| Q4 24 | 15.5% | -17.7% | ||
| Q3 24 | 2.7% | -5.1% | ||
| Q2 24 | 9.1% | 1.0% |
净利率BANCRGEN
| Q1 26 | 25.1% | — | ||
| Q4 25 | 16.9% | 6.7% | ||
| Q3 25 | 14.9% | 7.9% | ||
| Q2 25 | 6.3% | 8.2% | ||
| Q1 25 | 12.2% | 3.4% | ||
| Q4 24 | 12.6% | -17.4% | ||
| Q3 24 | 2.0% | -0.4% | ||
| Q2 24 | 6.2% | 2.2% |
每股收益（稀释后）BANCRGEN
| Q1 26 | $0.39 | — | ||
| Q4 25 | $0.41 | $0.24 | ||
| Q3 25 | $0.38 | $0.26 | ||
| Q2 25 | $0.12 | $0.26 | ||
| Q1 25 | $0.26 | $0.10 | ||
| Q4 24 | $0.29 | $-0.55 | ||
| Q3 24 | $-0.01 | $-0.01 | ||
| Q2 24 | $0.12 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.2B | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $3.6B | $2.1B |
| 总资产 | $34.7B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BANCRGEN
| Q1 26 | $2.2B | — | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务BANCRGEN
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | $542.2M | ||
| Q3 25 | $2.0B | $537.9M | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.4B | $525.6M | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.4B | — |
股东权益BANCRGEN
| Q1 26 | $3.6B | — | ||
| Q4 25 | $3.5B | $2.1B | ||
| Q3 25 | $3.5B | $2.1B | ||
| Q2 25 | $3.4B | $2.1B | ||
| Q1 25 | $3.5B | $2.0B | ||
| Q4 24 | $3.5B | $2.0B | ||
| Q3 24 | $3.5B | $2.0B | ||
| Q2 24 | $3.4B | $2.0B |
总资产BANCRGEN
| Q1 26 | $34.7B | — | ||
| Q4 25 | $34.8B | $2.9B | ||
| Q3 25 | $34.0B | $2.9B | ||
| Q2 25 | $34.3B | $2.9B | ||
| Q1 25 | $33.8B | $2.9B | ||
| Q4 24 | $33.5B | $2.8B | ||
| Q3 24 | $33.4B | $2.8B | ||
| Q2 24 | $35.2B | $2.9B |
负债/权益比BANCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 0.58× | 0.26× | ||
| Q3 25 | 0.58× | 0.26× | ||
| Q2 25 | 0.56× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.40× | 0.27× | ||
| Q3 24 | 0.46× | — | ||
| Q2 24 | 0.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流BANCRGEN
| Q1 26 | — | — | ||
| Q4 25 | $255.6M | $25.7M | ||
| Q3 25 | $75.7M | $48.1M | ||
| Q2 25 | $62.7M | $28.6M | ||
| Q1 25 | $15.1M | $15.0M | ||
| Q4 24 | $77.4M | $39.2M | ||
| Q3 24 | $46.9M | $49.3M | ||
| Q2 24 | $39.1M | $42.2M |
自由现金流BANCRGEN
| Q1 26 | — | — | ||
| Q4 25 | $234.8M | $17.6M | ||
| Q3 25 | $75.5M | $43.4M | ||
| Q2 25 | $61.4M | $21.5M | ||
| Q1 25 | $13.6M | $11.4M | ||
| Q4 24 | $64.3M | $33.6M | ||
| Q3 24 | $44.6M | $42.3M | ||
| Q2 24 | $34.4M | $37.4M |
自由现金流率BANCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 51.2% | 8.9% | ||
| Q3 25 | 16.2% | 23.0% | ||
| Q2 25 | 13.6% | 11.8% | ||
| Q1 25 | 3.1% | 6.8% | ||
| Q4 24 | 14.2% | 19.3% | ||
| Q3 24 | 10.3% | 27.3% | ||
| Q2 24 | 7.0% | 24.3% |
资本支出强度BANCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 4.5% | 4.1% | ||
| Q3 25 | 0.0% | 2.5% | ||
| Q2 25 | 0.3% | 3.9% | ||
| Q1 25 | 0.3% | 2.1% | ||
| Q4 24 | 2.9% | 3.2% | ||
| Q3 24 | 0.5% | 4.5% | ||
| Q2 24 | 1.0% | 3.1% |
现金转化率BANCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 3.30× | 1.93× | ||
| Q3 25 | 1.09× | 3.23× | ||
| Q2 25 | 2.21× | 1.92× | ||
| Q1 25 | 0.28× | 2.57× | ||
| Q4 24 | 1.36× | — | ||
| Q3 24 | 5.34× | — | ||
| Q2 24 | 1.29× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
